Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Impladent is a medical device company that specializes in the development and manufacture of innovative regenerative materials for the dental and oral surgery markets. The company is widely recognized for its proprietary OsteoGen product line, which features a resorbable synthetic bioactive crystal used for bone augmentation and ridge preservation. Unlike traditional grafts, Impladent's technology is designed to be osteoconductive and integrates directly into the healing bone without the need for a separate membrane in many applications. Their product portfolio also includes collagen plugs, strips, and membranes that support wound healing and tissue regeneration. Based in New York, Impladent has been a leader in the dental regenerative space for over three decades, providing clinicians with simplified and effective grafting solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Impladent.